What a 33% rise in coupling-reagent prices does to a 20 mg vial
Follow the resin, not the catalogue.
Lucía Berenguer
Page 17 of 18 of this archive, newest first.
Archive — page 17
356 piecesWhat changed at HJ in March, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What a 25% rise in coupling-reagent prices does to a 10 mg vial
Follow the resin, not the catalogue.
What changed at QSC in March, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
LAL, kinetic chromogenic, recombinant factor C: three ways to the same figure
Bacterial endotoxin is a heat-stable lipopolysaccharide from the outer membrane of Gram-negative organisms. It survives sterilisation, passes a sterilising filter, and is…
What a 23% rise in coupling-reagent prices does to a 15 mg vial
Follow the resin, not the catalogue.
Why FGP can be entirely straightforward and still tell you nothing about bioburden
The Journal has read several hundred certificates from twenty companies. We set out what the documents actually cover, and what a reader is filling in from imagination.
What changed at CPC in March, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What changed at WXT in March, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The reference change value: the number that tells you whether a delta is real
Almost every misreading of a laboratory panel is a misunderstanding of what a reference interval is and how much a result has to move before the movement means anything.
What changed at JEEP in February, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What changed at SWB in February, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What a 40% rise in coupling-reagent prices does to a 2 mg vial
Follow the resin, not the catalogue.
What a 7% rise in coupling-reagent prices does to a 30 mg vial
Follow the resin, not the catalogue.
What changed at SSA in February, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The one-quarter rule, and the paper that took it apart
The gap between a defensible recommendation and a confident one is where most of the harm in this subject lives.
What “LC-MS: conforms” tells a reader, which is almost nothing
None of what a checkable identity statement requires is commercially sensitive, and all of it is known to whoever produced the document.
What changed at SSA in February, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What changed at KP in February, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What a 7% rise in coupling-reagent prices does to a 5 mg vial
Follow the resin, not the catalogue.